Creative Biolabs Brings the Heat at Alzheimer’s Summit with ‘Brainiac’ Breakthroughs

New York, USA – March 19, 2025 – The Revere Hotel buzzed with excitement on March 19, as Creative Biolabs, a frontrunner in neuroscience solutions, dropped a mic-worthy keynote at the 13th Alzheimer’s & Parkinson’s Drug Development Summit.

“We’re not just chasing targets,” one of the delegates declared, spotlighting how their tools aim to crack the code on neurotoxic proteins like Aß and tau—the usual suspects in Alzheimer’s pathology. With Big Pharma scrambling to capitalize on the neurodegenerative drug boom, Creative Biolabs is positioning itself as the trustworthy partner for drug hunters. The talk aims to provide a playbook about:

* A novel neuroscience platform with state-of-the-art technologies for drug screening and MOA studies

* Using complex in vitro models in the context of neurodegenerative conditions

* Exploring the all-in-one approach for intricate phenotypes in AD and PD

The Swiss Army Knife: Neuroscience Sector

1. AD In Vitro Assays: iPSC Models That Don’t Miss a Beat

Forget cookie-cutter neurons. The company has developed AD in vitro assays that leverage induced pluripotent stem cells (iPSCs) to mimic human brain circuitry, letting researchers track Aß plaques and tau tangles in real time. “It’s like giving cells a Fitbit,” the delegate quipped.

2. AD Animal Models: Mice with a Ph.D. in Pathology

Their transgenic AD animal models are no lab amateurs. These rodents replicate amyloid and tau pathologies with eerie precision:

* Natural models

* Genetic models: APP transgenic mouse models and tau transgenic mouse models

* Interventional models

3. Neurodegenerative Modeling: 3D Brain & Beyond

Creative Biolabs’ neurodegenerative modeling portfolio now includes cell models and brain slice models that mimic brain tissue complexity. “Our skilled, genetically modified animal preparation platform enables us to provide animal models for your specific research goals.” The scientist explains.

4. Neural Toolbox: Tracers That Light Up the Dark

Their neural cell lines and neural tracers act like GPS for synaptic pathways, helping laboratories map neurodegeneration’s routes that are ambiguous in conventional tracking assays.

5. Primary CNS Assays: Inflammation’s Kryptonite

The primary CNS assay platform zeroes in on neuroinflammation and myelination—a one-two punch for diseases like MS.

Neurons: neuronal maturation assay, neuronal mitophagy assay, neurotoxicity assay, etc.

Glial cells: microglia assay, astrocyte assay, co-culture assay, etc.

Roadshow Alert: Where to Catch Creative Biolabs Next

Creative Biolabs 2025 biotech marathon kicks into high gear with these pit stops:

April 23, 2025 | NIH Spring Research Vendor Fair

May 7, 2025 | 23rd BioPharma Drug Discovery Nexus Conference

September 2025 | World Bispecific Summit

October 2025 | Exosome-Based Therapeutic Development Summit

November 2025 | World ADC San Diego

December 2025 | Antibody Engineering & Therapeutics (US) 2025

For more information: https://neuros.creative-biolabs.com

About

Creative Biolabs is upping the ante in neuroscience research and development, whether it’s neurodegeneration, immunotherapy, or cutting-edge biologics.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://neuros.creative-biolabs.com